StemCells, Inc. , today announced its intent to offer and sell 11,299,435 shares of common stock and short term warrants for the purchase of up to 9,604,520 additional shares of common stock to two well recognized institutional biotechnology investors, subject to market and other conditions, for gross proceeds of $20 million, before deducting ... (more)
http://ift.tt/1p2lK9c
http://ift.tt/1p2lK9c
No comments:
Post a Comment